Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews
Frontiers in Nutrition · 13.06.2025 · 12
DOI: 10.3389/fnut.2025.1559471 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 13.06.2025. Verfasst von Pavlo Petakh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vitamin D is suggested as a supportive therapy to reduce the severity of COVID-19 due to its immunomodulatory and anti-inflammatory effects. However, its effect on critical outcomes, such as ICU admissions and mortality, shows significant variation across randomized clinical trials and meta-analyses.
Objectives
To summarize the influence of vitamin D supplementation on ICU admissions and mortality among COVID-19 patients.
Methods
Overall, 21 eligible studies were retrieved using a comprehensive search from Scopus, PubMed, and Web of Science. A citation matrix was developed, revealing a Corrected Covered Area (CCA) of 0.54, indicating moderate overlap. Fixed-effects models were applied to data with low heterogeneity (ICU admissions: Q = 10.87, p = 0.33), while random-effects models were used for mortality outcomes (Q = 27.23, p = 0.006). Pooled odds ratios (OR) with 95% confidence intervals (CI) quantified the overall effects.
Results
Vitamin D supplementation was associated with a significant 38% reduction in ICU admissions (OR = 0.62; 95% CI: 0.54–0.71) and a 33% reduction in mortality risk (OR = 0.67; 95% CI: 0.56–0.79). The benefit was pronounced in vitamin D-deficient populations, although heterogeneity in mortality outcomes highlighted variability across studies.
Conclusion
While these findings suggest that vitamin D supplementation may help reduce ICU admissions and mortality among COVID-19 patients—particularly in those with vitamin D deficiency—the results should be interpreted with caution. The observed variability and potential confounding factors underscore the need for further large-scale, randomized controlled trials with standardized dosing protocols before definitive clinical recommendations can be made.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine.
- Department of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
- Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
- Department of Microbiology, Virology and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Zitieren
APA
Petakh, P., Kamyshna, I., Halabitska, I., & Kamyshnyi, O. (2025). Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1559471
Vancouver
Petakh P, Kamyshna I, Halabitska I, Kamyshnyi O. Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1559471
BibTeX
@article{Petakh2025,
author = {Petakh, Pavlo and Kamyshna, Iryna and Halabitska, Iryna and Kamyshnyi, Oleksandr},
title = {Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1559471}
}
EUVIMED